Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid reported fourth-quarter fiscal 2020 results with a wider-than-expected loss.

Why Shares of Rite Aid Plunged 26% Thursday Morning

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q4 2020 Results - Earnings Call Transcript

Rite Aid Corp. RAD, -6.52% shares sank 12.6% in Thursday premarket trading after the pharmacy retailer reported wider-than-expected losses in the fourth quarter.

Rite Aid shares sink 12% after wider-than-expected losses

Shares of Rite Aid (NYSE:RAD) fell 3% in pre-market trading after the company reported Q4 results.

Rite Aid: Q4 Earnings Insights

Rite Aid (RAD) adds another testing location at a Rite Aid store in Pennsylvania to help curb the effects of coronavirus pandemic.

Rite Aid Adds new Testing Site, Supports Coronavirus Relief Efforts

Best Buy

Costco

Sprouts Farmers Markets

As people are working from home and maintaining social distancing, there are players in the industry focusing on bolstering omni-channel operations and ramping up delivery services.

Coronavirus Ruining Portfolio? Give These 4 Retailers a Shot

The pharmacy chain operator aims to soon be capable of performing more than 5,000 tests a day.

Rite Aid to Open More COVID-19 Testing Sites in 7 States

Rite Aid (RAD) has been working at the forefront by providing essential goods and medicines as well as assisting with coronavirus testing and virus-related information.

Rite Aid (RAD) Prioritizes Actions Amid Coronavirus Woes

Rite Aid Corp. RAD, +3.95% said Tuesday it plans to expand COVID-19 testing sites, including new drive-up locations with self-swab nasal tests, as part of its partnership with the White House Coronavirus Task Force.

Rite Aid adds new COVID-19 testing site in Pennsylvania, to add drive-up self-swab testing sites in 7 states

Rite Aid's (RAD) fourth-quarter fiscal 2020 results are likely to reflect gains from increased Medicare Part D membership and improved pharmacy network as well as enhanced wellness offerings.

Will Rite Aid's (RAD) Strategies Continue to Aid Q4 Earnings?

Rite Aid has been taking steps to serve customers and healthcare workers more effectively in the national battle against the outbreak. But will they translate into higher earnings in April?

Is Rite Aid Stock a Buy Before This Week’s Earnings Report?

Bed Bath & Beyond

Johnson & Johnson

Johnson & Johnson is one of several companies that will have important news to share in the next few trading days.

3  Things to Watch in the Stock Market  This Week

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rite Aid (RAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

JPMorgan Chase & Co

Kansas City Southern

Schlumberger

UnitedHealth Group

These seven earnings reports next week are worth highlighting. Here's what you might expect when each of these companies makes their report.

7 Earnings Reports to Watch Next Week (April 09)

In the wake of the COVID-19 crisis, Rite Aid (RAD) is gearing up to serve customers better by hiring staff. Also, its newly-launched Hero plan bodes well.

Rite Aid Continues Hiring to Support Coronavirus Relief Efforts

Rite Aid (RAD) is expected to have witnessed soft front-end sales in fourth-quarter fiscal 2020, due to restrictions on sale of tobacco in New York, and over-the-counter cough-cold and flu products.

Factors Setting the Tone for Rite Aid's (RAD) Q4 Earnings

The company is bolstering its workforce in response to the coronavirus pandemic.

Rite Aid Hiring 5,000 Workers and Raising Pay

CVS Health

Walgreens

All three retail pharmacy giants take a step back after Walgreens withdraws its full-year outlook.

Why Walgreens Boots Alliance, CVS Health, and Rite Aid Are Falling Today

Rite Aid (RAD) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

American Outdoor Brands

Booz Allen Hamilton Hld

Clorox

Lockheed Martin

Sportsman's Warehouse Hlds

Should the economy not bounce back following the coronavirus, you’ll want to look at these recession-resistant stocks to buy.
The post 9 Stocks to Buy to Weather the Recession appeared first on InvestorPlace.

9 Stocks to Buy to Weather the Recession

Lumber Liquidators

Experts believe that once the coronavirus spread is contained, the retail sector, which touches every sphere of our life, is likely to witness a sharp rebound.

5 Retail Picks for a Dose of Confidence Amid Coronavirus-Crisis

Casey's General Stores

Experts believe that once the coronavirus spread is contained and vaccine discovered, the retail sector, which touches every sphere of our life, is likely to witness a sharp rebound.

Are There Any Stocks to Buy in Coronavirus-Hit Retail Sector?

Breweries, distilleries, and other companies will be able to help meet soaring demand if they follow the WHO's recipe.

FDA Relaxes Rules on Hand Sanitizer Producers Amid the Coronavirus Pandemic

Amazon

JD.com

J. M. Smucker

ShotSpotter

Stamps.com

Veeva Systems

These stocks have defied the 2020 selloff. This means they may be stocks to buy for investors betting a broad market bottom is on the way.

7 Stocks to Buy That Have Survived the Recent Carnage

In the wake of the COVID-19 crisis, Rite Aid (RAD) is gearing up to serve customers better by providing home delivery and pick-up services.

News for Rite Aid Stock (RAD)